Daniela Muhr

927 total citations
29 papers, 633 citations indexed

About

Daniela Muhr is a scholar working on Genetics, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Daniela Muhr has authored 29 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 11 papers in Molecular Biology and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Daniela Muhr's work include BRCA gene mutations in cancer (13 papers), DNA Repair Mechanisms (5 papers) and Ovarian cancer diagnosis and treatment (5 papers). Daniela Muhr is often cited by papers focused on BRCA gene mutations in cancer (13 papers), DNA Repair Mechanisms (5 papers) and Ovarian cancer diagnosis and treatment (5 papers). Daniela Muhr collaborates with scholars based in Austria, Germany and United States. Daniela Muhr's co-authors include Teresa Wagner, Peter J. Oefner, Oliver Schnell, Eberhard Standl, M. Haslbeck, S. Dresel, Dominique Stoppa‐Lyonnet, Åke Borg, Therese Sandberg and Sabine Pagès and has published in prestigious journals such as PLoS ONE, Diabetes Care and Diabetes.

In The Last Decade

Daniela Muhr

27 papers receiving 614 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniela Muhr Austria 13 283 257 134 113 112 29 633
Gong-Qing Shen United States 14 461 1.6× 346 1.3× 254 1.9× 138 1.2× 84 0.8× 25 1.1k
Tomoko Saito Japan 14 521 1.8× 63 0.2× 55 0.4× 333 2.9× 113 1.0× 38 813
Armina A. Kazi United States 13 394 1.4× 169 0.7× 20 0.1× 192 1.7× 205 1.8× 22 708
Bernhard Gess Germany 15 402 1.4× 100 0.4× 107 0.8× 249 2.2× 55 0.5× 21 751
Sander W. van der Laan Netherlands 14 251 0.9× 152 0.6× 118 0.9× 70 0.6× 48 0.4× 58 692
Vidar Staalesen Norway 11 299 1.1× 68 0.3× 74 0.6× 117 1.0× 159 1.4× 12 654
Erin L. Reineke United States 14 491 1.7× 133 0.5× 88 0.7× 66 0.6× 110 1.0× 20 691
Jarkko Soronen Finland 12 314 1.1× 64 0.2× 196 1.5× 175 1.5× 108 1.0× 15 652
Sachi Hoshi Japan 7 247 0.9× 91 0.4× 43 0.3× 60 0.5× 62 0.6× 8 547
Huy Q. Ta United States 12 266 0.9× 104 0.4× 24 0.2× 73 0.6× 159 1.4× 24 605

Countries citing papers authored by Daniela Muhr

Since Specialization
Citations

This map shows the geographic impact of Daniela Muhr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Muhr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Muhr more than expected).

Fields of papers citing papers by Daniela Muhr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela Muhr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Muhr. The network helps show where Daniela Muhr may publish in the future.

Co-authorship network of co-authors of Daniela Muhr

This figure shows the co-authorship network connecting the top 25 collaborators of Daniela Muhr. A scholar is included among the top collaborators of Daniela Muhr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela Muhr. Daniela Muhr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Tan, Yen Y., et al.. (2023). A de Novo BRCA1 Pathogenic Variant in a 29-Year-Old Woman with Triple-Negative Breast Cancer. Breast Care. 18(5). 412–416. 1 indexed citations
4.
Singer, Christian F., Yen Y. Tan, Daniela Muhr, et al.. (2019). Association between family history, mutation locations, and prevalence of BRCA1 or 2 mutations in ovarian cancer patients. Cancer Medicine. 8(4). 1875–1881. 20 indexed citations
5.
Tan, Yen Y., et al.. (2018). Differential Claudin 3 and EGFR Expression Predicts BRCA1 Mutation in Triple-Negative Breast Cancer. Cancer Investigation. 36(7). 378–388. 6 indexed citations
6.
Gschwantler‐Kaulich, Daphne, Dietmar Pils, Daniela Muhr, et al.. (2017). Diagnostic markers for the detection of ovarian cancer in BRCA1 mutation carriers. PLoS ONE. 12(12). e0189641–e0189641. 8 indexed citations
7.
Gschwantler‐Kaulich, Daphne, Thomas W. Grunt, Daniela Muhr, et al.. (2016). HER Specific TKIs Exert Their Antineoplastic Effects on Breast Cancer Cell Lines through the Involvement of STAT5 and JNK. PLoS ONE. 11(1). e0146311–e0146311. 21 indexed citations
8.
Tea, Muy‐Kheng M., Regina Kroiss, Daniela Muhr, et al.. (2013). Central European BRCA2 mutation carriers: Birth cohort status correlates with onset of breast cancer. Maturitas. 77(1). 68–72. 15 indexed citations
9.
Singer, CF, Christine Rappaport, Daniela Muhr, et al.. (2012). Presence of Intratumoral Stem Cells in Breast Cancer Patients with or without BRCA Germline Mutations. Current Cancer Drug Targets. 12(1). 44–50. 4 indexed citations
10.
Kroiss, Regina, Margaretha Rudas, Daniela Muhr, et al.. (2008). Prevalence of pre-malignant and malignant lesions in prophylactic mastectomy specimens of BRCA1 mutation carriers: comparison with a control group. Journal of Cancer Research and Clinical Oncology. 134(10). 1113–1121. 9 indexed citations
11.
Kroiss, Regina, Florian Frommlet, Daniela Muhr, et al.. (2005). Younger birth cohort correlates with higher breast and ovarian cancer risk in EuropeanBRCA1 mutation carriers. Human Mutation. 26(6). 583–589. 15 indexed citations
12.
Thorstenson, Yvonne R., Regina Kroiss, Mark A. Jenkins, et al.. (2003). Contributions of ATM mutations to familial breast and ovarian cancer.. PubMed. 63(12). 3325–33. 135 indexed citations
13.
Muhr, Daniela, Teresa Wagner, & Peter J. Oefner. (2002). Polymerase chain reaction fidelity and denaturing high-performance liquid chromatography. Journal of Chromatography B. 782(1-2). 105–110. 11 indexed citations
14.
Meier, Matthias, et al.. (2000). QTc interval and scintigraphically assessed myocardial perfusion in newly diagnosed and long-term type 1 diabetes mellitus. Journal of Diabetes and its Complications. 14(2). 90–95. 8 indexed citations
15.
Wagner, Teresa, Dominique Stoppa‐Lyonnet, Daniela Muhr, et al.. (1999). Denaturing High-Performance Liquid Chromatography Detects Reliably BRCA1 and BRCA2 Mutations. Genomics. 62(3). 369–376. 179 indexed citations
16.
Schnell, Oliver, Daniela Muhr, Carl‐Martin Kirsch, et al.. (1997). Three-year follow-up on scintigraphically assessed cardiac sympathetic denervation in patients with long-term insulin-dependent (type I) diabetes mellitus. Journal of Diabetes and its Complications. 11(5). 307–313. 15 indexed citations
18.
Standl, Eberhard, Oliver Schnell, Bernd Balletshofer, et al.. (1997). Influence of diabetes mellitus on the heart and macrovascular mortality. Diabetologia. 40(0). S125–S126. 4 indexed citations
19.
Muhr, Daniela, U. Mollenhauer, Anette‐Gabriele Ziegler, et al.. (1997). Autoantibodies to Sympathetic Ganglia, GAD, or Tyrosine Phosphatase in Long-Term IDDM With and Without ECG-Based Cardiac Autonomic Neuropathy. Diabetes Care. 20(6). 1009–1012. 16 indexed citations
20.
Schnell, Oliver, et al.. (1996). Reduced myocardial 123I-metaiodobenzylguanidine uptake in newly diagnosed IDDM patients. Diabetes. 45(6). 801–805. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026